Drug Shortage Report for LUNESTA

Last updated on 2024-12-18 History
Report ID 238550
Drug Identification Number 02453223
Brand name LUNESTA
Common or Proper name eszopiclone tablets USP
Company Name SUMITOMO PHARMA CANADA, INC.
Market Status MARKETED
Active Ingredient(s) ESZOPICLONE
Strength(s) 3MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100 tablets/bottle
ATC code N05CF
ATC description
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2024-10-15
Actual start date 2024-10-15
Estimated end date 2024-12-20
Actual end date 2024-12-17
Shortage status Resolved
Updated date 2024-12-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 7025 LANGER DRIVE
MISSISSAUGA, ONTARIO
CANADA L5N 0E8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2024-12-18 English Compare
v11 2024-12-17 French Compare
v10 2024-12-17 English Compare
v9 2024-12-12 French Compare
v8 2024-12-12 English Compare
v7 2024-11-25 French Compare
v6 2024-11-25 English Compare
v5 2024-10-16 French Compare
v4 2024-10-16 English Compare
v3 2024-10-16 English Compare
v2 2024-09-26 French Compare
v1 2024-09-26 English Compare

Showing 1 to 12 of 12